Literature DB >> 23211296

Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificity.

Brooke E Howitt1, Marisa R Nucci, Ronny Drapkin, Christopher P Crum, Michelle S Hirsch.   

Abstract

A fundamental controversy in using biomarkers to diagnose cervical cancer precursors [ie, squamous intraepithelial lesions (SIL)] is their lack of specificity for high-grade SIL [HSIL; cervical intraepithelial neoplasia grade 2/3 (CIN2/3)]. Stathmin-1 (STMN), a microtubule-destabilizing protein important in mitosis, is overexpressed in a variety of malignancies including those from the Müllerian tract and may be associated with poor outcome. However, the use of STMN as a diagnostic marker in cervical SILs has not been explored. A total of 193 cervical samples, including benign cervix and squamous and glandular lesions, were evaluated for STMN, p27 (a known cell cycle regulator inversely expressed with STMN in normal and many neoplastic tissues), p16, and Ki67 expression by immunohistochemical analysis. SILs were independently scored and classified as benign, low-grade SIL (LSIL/CIN1), and HSIL (separated into CIN2 or CIN3) on the basis of a majority diagnosis. Each diagnosis was correlated with biomarker expression independent of hematoxylin and eosin review. STMN was normally expressed in basal cells of the ectocervix and was absent in benign endocervix;"positive" STMN staining was defined as immunoreactivity in at least two thirds of the epithelial thickness. A majority hematoxylin and eosin diagnosis was obtained in 189/193 cases on initial independent review, with squamous epithelia ultimately classified as benign, CIN1, CIN2, and CIN3 in 25, 56, 11, and 16 cases, respectively. STMN was positive in 5/56 (9%) CIN1, 5/11 (45%) CIN2, 14/15 (93%) CIN3, all adenocarcinoma in situ (19/19), and all invasive squamous cell carcinoma (32/32) and adenocarcinoma (34/34) cases. In contrast, 40/56 (71%) CIN1, 11/11 (100%) CIN2, and 15/16 (94%) CIN3 lesions were p16 positive (defined as diffuse block staining in at least one third of the epithelial thickness). One CIN3 was negative for both p16 and STMN. Ki67 and p27 staining was variable in squamous lesions. These results demonstrate that STMN is overexpressed in virtually all cervical carcinomas and CIN3 lesions. In contrast to p16, which often stains LSIL and a small subset of reactive biopsies, STMN has greater specificity for CIN3 and has the potential to distinguish these latter lesions from the majority of low-grade precursors and negative/reactive cervical biopsies. STMN overexpression appears independent of proliferation, maturation, and human papilloma virus cytopathic effect and may be useful diagnostically in identifying HSIL. Further studies correlating STMN staining with lesion persistence or morphologic progression, in the context of CIN grade, are warranted.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23211296     DOI: 10.1097/PAS.0b013e3182753f5a

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  9 in total

1.  An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.

Authors:  Mary-Margaret L Allen; Jonathan J Douds; Sharon X Liang; Mohamed M Desouki; Vinita Parkash; Oluwole Fadare
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  miR-193b directly targets STMN1 and inhibits the malignant phenotype in colorectal cancer.

Authors:  Feng Guo; Yang Luo; Yi-Fei Mu; Shao-Lan Qin; Yang Qi; Yi-Er Qiu; Ming Zhong
Journal:  Am J Cancer Res       Date:  2016-11-01       Impact factor: 6.166

3.  Cervical Strip Biopsy for High-Grade Cervical Intraepithelial Lesions: a Valid Alternative to Conventional Punch Technique.

Authors:  A Schneider; K Wagner; C Rakozy; C Stolte; P Bothur-Schäfer; T Welcker; N Choly; A Roesgen; H Rothe; G Böhmer
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-10       Impact factor: 2.915

4.  Increased RIPK4 expression is associated with progression and poor prognosis in cervical squamous cell carcinoma patients.

Authors:  De-Qing Liu; Fang-Fang Li; Jiang-Bo Zhang; Tie-Jun Zhou; Wen-Qiong Xue; Xiao-Hui Zheng; Yuan-Bin Chen; Xiao-Yu Liao; Lan Zhang; Shao-Dan Zhang; Ye-Zhu Hu; Wei-Hua Jia
Journal:  Sci Rep       Date:  2015-07-07       Impact factor: 4.379

5.  Stathmin 1 expression predicts prognosis and benefits from adjuvant chemotherapy in patients with gallbladder carcinoma.

Authors:  Xiaobo Bo; Jie Wang; Qiang Fu; Yueqi Wang; Houbao Liu; Jiejie Xu
Journal:  Oncotarget       Date:  2017-07-27

6.  Stathmin is overexpressed and regulated by mutant p53 in oral squamous cell carcinoma.

Authors:  Hai-Long Ma; Shu-Fang Jin; Wu-Tong Ju; Yong Fu; Yao-Yao Tu; Li-Zhen Wang; Zhi-Yuan Zhang; Lai-Ping Zhong
Journal:  J Exp Clin Cancer Res       Date:  2017-08-14

Review 7.  Overexpression of stathmin promotes metastasis and growth of malignant solid tumors: a systemic review and meta-analysis.

Authors:  Rong Biaoxue; Liu Hua; Gao Wenlong; Yang Shuanying
Journal:  Oncotarget       Date:  2016-11-29

8.  p16 is superior to Stathmin-1 and HSP27 in identifying cervical dysplasia.

Authors:  Sofia Liou; Neshat Nilforoushan; Yuna Kang; Neda A Moatamed
Journal:  Diagn Pathol       Date:  2021-09-20       Impact factor: 2.644

Review 9.  Stathmin-dependent molecular targeting therapy for malignant tumor: the latest 5 years' discoveries and developments.

Authors:  Rong Biaoxue; Cai Xiguang; Liu Hua; Yang Shuanying
Journal:  J Transl Med       Date:  2016-09-27       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.